Equibles does not estimate personal net worth.
Sean Singh is recorded as CEO at Vistagen Therapeutics, Inc. (VTGN). Sean Singh has spoken on 1 earnings call across 1 company, most recently for Vistagen Therapeutics, Inc. on February 12, 2026. Vistagen Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Vistagen Therapeutics, Inc. includes Shawn K. Singh (CEO and Board Member), Cynthia Anderson (CFO), Nick B. Tressler (CFO and Chief Accounting Officer) and 7 others.
“It's been an important quarter for our team with the completion of the randomized portion of our Palisade III Phase III trial in social anxiety disorder as guided and focused efforts to learn from the study's results and drive high quality and efficient execution of our ongoing Palisade IV Phase III trial.”
Biotechnology · Healthcare
CEO
